BioNTech SE (BNTX) Work In Process (2018 - 2021)
BioNTech SE (BNTX) posted Work In Process of $96.7 million for Q4 2021, up 317.92% sequentially from $23.1 million in Q4 2020, and up 317.92% YoY from $23.1 million in Q4 2020.
BioNTech SE (BNTX) Work In Process (2018 - 2021) Analysis & Trends
BioNTech SE has reported Work In Process for 4 years, with the latest figure at $96.7 million in Q4 2021.
- Quarterly Work In Process rose 317.92% year-over-year to $96.7 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $96.7 million (up 317.92% YoY) and the FY2021 annual result came in at $100.0 million, up 351.45% from the prior year.
- Work In Process improved to $96.7 million in Q4 2021 per BNTX's latest filing, from $23.1 million in the prior quarter.
- Over five years, Work In Process peaked at $96.7 million in Q4 2021 and troughed at $91311.7 in Q4 2018.
- A 4-year average of $30.8 million and a median of $13.2 million in 2019 frame the typical range for Work In Process.
- The sharpest annual moves came in 2019 and 2021: Work In Process jumped 3400.86% in 2019, then soared 317.92% in 2021.
- Over 4 years, Work In Process stood at $91311.7 in 2018, then surged by 3400.86% to $3.2 million in 2019, then soared by 623.57% to $23.1 million in 2020, then jumped by 317.92% to $96.7 million in 2021.
- According to Business Quant data, Work In Process over the past three periods registered $96.7 million, $23.1 million, and $3.2 million for Q4 2021, Q4 2020, and Q4 2019 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | BioNTech SE | 23.54 Bn | 5.15 Bn | 668.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 96.67 Mn |
| Dec 31, 2020 | 23.13 Mn |
| Dec 31, 2019 | 3.20 Mn |
| Dec 31, 2018 | 91,311.71 |